Debating the definition of airflow obstruction: time to move on? Miller M. R., Pedersen O. F., Pellegrino R., Brusasco V. Eur Respir J 2009; 34: 527 | |
Liver toxicity: the Achilles' heel of endothelin receptor antagonist therapy? Hoeper M. M. Eur Respir J 2009; 34: 529 | |
Medicines used in respiratory diseases only seen in children Lenney W., Boner A. L., Bont L., Bush A., Carlsen K-H., Eber E., Fauroux B., Gotz M., Greenough A., Grigg J., Hull J., Kimpen J., Sanchez Luna M., de Benedictis F. M. Eur Respir J 2009; 34: 531 | |
How to increase the value of randomised trials in COPD research Puhan M. A., Schunemann H. J. Eur Respir J 2009; 34: 552 | |
Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma Song Y., Li X., Du X. Eur Respir J 2009; 34: 559 | |
What defines airflow obstruction in asthma? Cerveri I., Corsico A. G., Accordini S., Cervio G., Ansaldo E., Grosso A., Niniano R., Tsana Tegomo E., Anto J. M., Kunzli N., Janson C., Sunyer J., Svanes C., Heinrich J., Schouten J. P., Wjst M., Pozzi E., de Marco R. Eur Respir J 2009; 34: 568 | |
Serial PEF measurement is superior to cross-shift change in diagnosing occupational asthma Park D., Moore V. C., Burge C. B. S. G., Jaakkola M. S., Robertson A. S., Burge P. S. Eur Respir J 2009; 34: 574 | |
Control and severity of asthma during pregnancy are associated with asthma incidence in offspring: two-stage case-control study Martel M-J., Rey E., Beauchesne M-F., Malo J-L., Perreault S., Forget A., Blais L. Eur Respir J 2009; 34: 579 | |
Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study Vollmer W. M., Gislason Th., Burney P., Enright P. L., Gulsvik A., Kocabas A., Buist A. S. Eur Respir J 2009; 34: 588 | |
CTLA4 gene polymorphisms are associated with chronic bronchitis Zhu G., Agusti A., Gulsvik A., Bakke P., Coxson H., Lomas D. A., Silverman E. K., Pillai S. G., ICGN investigators Eur Respir J 2009; 34: 598 | |
Physiological responses to linear treadmill and cycle ergometer exercise in COPD Hsia D., Casaburi R., Pradhan A., Torres E., Porszasz J. Eur Respir J 2009; 34: 605 | |
Decreased hyaluronan in airway smooth muscle cells from patients with asthma and COPD Klagas I., Goulet S., Karakiulakis G., Zhong J., Baraket M., Black J. L., Papakonstantinou E., Roth M. Eur Respir J 2009; 34: 616 | |
Second-hand smoke exposure in cars and respiratory health effects in children Kabir Z., Manning P. J., Holohan J., Keogan S., Goodman P. G., Clancy L. Eur Respir J 2009; 34: 629 | |
Smoking cessation interventions in COPD: a network meta-analysis of randomised trials Strassmann R., Bausch B., Spaar A., Kleijnen J., Braendli O., Puhan M. A. Eur Respir J 2009; 34: 634 | |
Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results Crim C., Calverley P. M. A.,,erson J. A., Celli B., Ferguson G. T., Jenkins C., Jones P. W., Willits L. R., Yates J. C., Vestbo J. Eur Respir J 2009; 34: 641 | |
Development and first validation of the COPD Assessment Test Jones P. W., Harding G., Berry P., Wiklund I., Chen W-H., Kline Leidy N. Eur Respir J 2009; 34: 648 | |
Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis Brennan S., Sly P. D., Gangell C. L., Sturges N., Winfield K., Wikstrom M., Gard S., Upham J. W., on behalf of AREST CF Eur Respir J 2009; 34: 655 | |
Growth factors and interleukin-6 across the lung circulation in pulmonary hypertension Selimovic N., Bergh C-H.,,ersson B., Sakiniene E., Carlsten H., Rundqvist B. Eur Respir J 2009; 34: 662 | |
Effects of exercise training in patients with idiopathic pulmonary arterial hypertension de Man F. S., Handoko M. L., Groepenhoff H., van 't Hul A. J., Abbink J., Koppers R. J. H., Grotjohan H. P., Twisk J. W. R., Bogaard H-J., Boonstra A., Postmus P. E., Westerhof N., van der Laarse W. J., Vonk-Noordegraaf A. Eur Respir J 2009; 34: 669 | |
CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis Busuttil A., Weigt S. S., Keane M. P., Xue Y. Y., Palchevskiy V., Burdick M. D., Huang C., Zisman D. A., Fishbein M., Lynch J. P. III, Strieter R. M., Elashoff R. M., Belperio J. A. Eur Respir J 2009; 34: 676 | |
Predictors of residual sleepiness in adequately treated obstructive sleep apnoea patients Koutsourelakis I., Perraki E., Economou N. T., Dimitrokalli P., Vagiakis E., Roussos C., Zakynthinos S. Eur Respir J 2009; 34: 687 | |
Sibutramine versus continuous positive airway pressure in obese obstructive sleep apnoea patients Ferland A., Poirier P., Series F. Eur Respir J 2009; 34: 694 | |
Impaired detection of Mycobacterium tuberculosis immunity in patients using high levels of immunosuppressive drugs Sester U., Wilkens H., van Bentum K., Singh M., Sybrecht G. W., Schafers H-J., Sester M. Eur Respir J 2009; 34: 702 | |
Informed participation in a randomised controlled trial of computed tomography screening for lung cancer van den Bergh K. A. M., Essink-Bot M. L., van Klaveren R. J., de Koning H. J. Eur Respir J 2009; 34: 711 | |
Azithromycin has an antiproliferative and autophagic effect on airway smooth muscle cells Stamatiou R., Paraskeva E., Boukas K., Gourgoulianis K. I., Molyvdas P-A., Hatziefthimiou A. A. Eur Respir J 2009; 34: 721 | |
Cirrhosis ameliorates monocrotaline-induced pulmonary hypertension in rats Le Pavec J., Perros F., Eddahibi S., Decante B., Dorfmuller P., Sitbon O., Lebrec D., Humbert M., Mazmanian M., Herve P. Eur Respir J 2009; 34: 731 | |
Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury Kumamoto M., Nishiwaki T., Matsuo N., Kimura H., Matsushima K. Eur Respir J 2009; 34: 740 | |
Mature CD11c+ cells are enhanced in hypersensitivity pneumonitis Girard M., Israel-Assayag E., Cormier Y. Eur Respir J 2009; 34: 749 | |
Emerging inhaled bronchodilators: an update Cazzola M., Matera M. G. Eur Respir J 2009; 34: 757 | |
Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension Lavelle A., Sugrue R., Lawler G., Mulligan N., Kelleher B., Murphy D. M., Gaine S. P. Eur Respir J 2009; 34: 770 | |
Combination of ENaC and CFTR mutations may predispose to cystic fibrosis-like disease Fajac I., Viel M., Gaitch N., Hubert D., Bienvenu T. Eur Respir J 2009; 34: 772 | |
Diagnosis of a posterior mediastinal goitre via endobronchial ultrasound-guided transbronchial needle aspiration Jeebun V., Natu S., Harrison R. Eur Respir J 2009; 34: 773 | |
Sex, forced expiratory volume in 1 s decline, body weight change and C-reactive protein in COPD patients de Torres J. P., Casanova C., Celli B. R. Eur Respir J 2009; 34: 776 | |
From the authors: Bridevaux P-O., Gerbase M., Rochat T. Eur Respir J 2009; 34: 777 | |
MDR-TB and XDR-TB: drug resistance and treatment outcomes Migliori G. B., Sotgiu G., D'Arcy Richardson M., Centis R., Facchini A., Guenther G., Spanevello A., Lange C., for TBNET Eur Respir J 2009; 34: 778 | |
To the Editors: Khurana A. K., Mohapatra P. R. Eur Respir J 2009; 34: 780 | |
ERS/ESTS CLINICAL GUIDELINES ON FITNESS FOR RADICAL THERAPY IN LUNG CANCER PATIENTS (SURGERY AND CHEMO-RADIOTHERAPY). A. BRUNELLI, A. CHARLOUX, C.T. BOLLIGER, G. ROCCO, J-P. SCULIER, G. VARELA, M. LICKER, M.K. FERGUSON, C. FAIVRE-FINN, R.M. HUBER, E.M. CLINI, T. WIN, D. DE RUYSSCHER AND L. GOLDMAN ON BEHALF OF THE EUROPEAN RESPIRATORY SOCIETY AND EUROPEAN SOCIETY OF THORACIC SURGEONS JOINT TASK FORCE ON FITNESS FOR RADICAL THERAPY. EUR RESPIR J 2009; 34: 17-41.
Eur Respir J 2009; 34: 782 | |
EFFECTS OF CICLESONIDE AND FLUTICASONE ON CORTISOL SECRETION IN PATIENTS WITH PERSISTENT ASTHMA. E. DEROM, R. LOUIS, C. TIESLER, R. ENGELSTATTER, J-M. KAUFMAN AND G.F. JOOS. EUR RESPIR J 2009; 33: 1277-1286.
Eur Respir J 2009; 34: 783 | |
DISSOCIATION OF AIRWAY INFLAMMATION AND HYPERRESPONSIVENESS BY CYCLOOXYGENASE INHIBITION IN ALLERGEN CHALLENGED MICE. L. SWEDIN, T. NEIMERT-ANDERSSON, J. HJOBERG, S. JONASSON, M. VAN HAGE, M. ADNER, A. RYRFELDT AND S-E. DAHLEN. EUR RESPIR J 2009; 34: 200-208.
Eur Respir J 2009; 34: 784 | |
Tuberculosis: A Comprehensive Clinical Reference Migliori G.B., Huggett J. Eur Respir J 2009; 34: 785 | |